S. 1681 · 115th Congress
A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.
- Stage
- In committee
- Sponsor
- Bernie Sanders
- Introduced
- 2017-07-31
- Latest action
- 2017-07-31 · Introduced in Senate
Action history
- 2017-07-31Introduced in Senate
- 2017-07-31Read twice and referred to the Committee on Health, Education, Labor, and Pensions.